0 items USD 0.00Search
Your search for "delveinsight metastatic prostate cancer api insights 2014" gave back 195971 results.
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
Enzalutamide is an orally bioavailable, organic, non-steroidal small molecule targeting the androgen receptor (AR) with potential antineoplastic...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Rucaparib API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period...
Catalog:
MRRPB5
September 2023
Price: USD 2,900.00
The global Rucaparib API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of %...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Osimertinib Mesylate API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (...
Catalog:
MRRPB5
July 2023
Price: USD 4,900.00
The global Dacomitinib API market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-...
Catalog:
GIR
March 2024
Price: USD 4,480.00
The global Dacomitinib API market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of...
Catalog:
GIR
March 2024
Price: USD 3,480.00
Relugolix is used to treat prostate cancer in men. Publisher' newest research report, the “Relugolix API Industry Forecast” looks at past sales...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Relugolix is used to treat prostate cancer in men. This report studies the global Relugolix API production, demand, key manufacturers, and key...
Catalog:
GIR
January 2023
Price: USD 4,480.00
Relugolix is used to treat prostate cancer in men. According to our latest study, the global Relugolix API market size was valued at USD million in...
Catalog:
GIR
January 2023
Price: USD 3,480.00
Relugolix is used to treat prostate cancer in men. The global Relugolix API market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into...
Catalog:
HYR
August 2021
Price: USD 2,930.00
Summary Cancer Treatment Drugs are used to treat malignancies, or cancerous growths. Depending on the technology it cans classification into...
Catalog:
HYR
May 2022
Price: USD 2,930.00
Nilutamide is a nonsteroidal antiandrogen, but has no effect on other steroid receptors.For metastatic prostate cancer. The “Nilutamide Industry...
Catalog:
LPI
March 2023
Price: USD 3,660.00
